P111: Phase I Trial of Brentuximab Vedotin plus Cyclosporine in Relapsed/Refractory Hodgkin Lymphoma

Detalles Bibliográficos
Autores principales: Kambhampati, Swetha, Mei, Matthew, Chen, Lu, Puvurel, Sandrine, Chen, Robert, Popplewell, Leslie, Nikolaenko, Liana, Peters, Lacolle, Armenian, Saro, Kwak, Larry, Rosen, Steven T., Forman, Stephen, Herrera, Alex F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Relapsed/Refractory
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9642054/
http://dx.doi.org/10.1097/01.HS9.0000891012.42031.20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9642054/
http://dx.doi.org/10.1097/01.HS9.0000891012.42031.20

Ejemplares similares